Sun Pharmaceutical Industries Ltd has asked SEBI to investigate in its 'entirety' the matter of a whistleblower's complaints. SEBI should lose no time in doing so. Sun Pharma has also asked for the role of some media houses and some entities' trade practices to be investigated. But that is of secondary interest. Investors want certainty. That will come when Sun Pharma's guilt or innocence is established. Guilt could hurt its shares further but certainty should return and then, time is a good healer. Otherwise, investors will be left fearing yet another whistleblower complaint that will send Sun Pharma's shares plunging.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
